LegoChem Biosciences Inc
KOSDAQ:141080
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Relative Value
The Relative Value of one LegoChem Biosciences Inc stock under the Base Case scenario is 16 272.51 KRW. Compared to the current market price of 66 800 KRW, LegoChem Biosciences Inc is Overvalued by 76%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
LegoChem Biosciences Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
KR |
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
2.4T KRW | 41.8 | -51.7 | -42.9 | -39.5 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
219.8B USD | 5.2 | 36.4 | 22.7 | 33.2 | ||
US |
Danaher Corp
NYSE:DHR
|
193.5B USD | 4.4 | 24 | 17.4 | 21.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
34.7B CHF | 5.2 | 53 | 18.2 | 26.7 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
39.3B USD | 2.6 | 28.9 | 15.6 | 24.1 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
53.1T KRW | 13.5 | 59.3 | 31 | 45.4 | ||
US |
Agilent Technologies Inc
NYSE:A
|
38.5B USD | 5.8 | 31 | 25.4 | 30.5 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
30.8B USD | 8.1 | 39.6 | 27 | 30.1 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.2B USD | 3.2 | 38.4 | 17.3 | 26.6 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24B USD | 8.2 | 42.1 | 29.2 | 35.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
17.1B EUR | 6.3 | 67.3 | 29.3 | 48.1 |